Clinical trial No longer in our active list Interventional Ages 6 to 18

Using rTMS with AI to help children with dyslexia improve reading skills

Official title: Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) as an Adjunct to AI Enabled Remedial Intervention in School Going Children (Aged 6-18 Years) Having Specific Learning Disorder With Dyslexia

Run by All India Institute of Medical Sciences, New Delhi · NCT05923645 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if using a special brain treatment along with an AI program can help children with dyslexia improve their reading skills better than regular methods.

Quick facts

Study typeInterventional
Ages6 Years to 18 Years
SexAll
Enrollment60 (estimated)
SponsorAll India Institute of Medical Sciences, New Delhi
Academic / other
Locations1 site (Delhi)
Trial IDNCT05923645 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Indian school-aged children between 6-18 years old diagnosed with dyslexia and whose parents are willing to participate.

Probably not a fit

Patients who have received remedial intervention within the last 12 weeks or have other neurological or psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of high-frequency repetitive Transcranial Magnetic Stimulation (Hf rTMS) as an adjunct to an AI-enabled remedial intervention for children diagnosed with dyslexia. The trial will involve screening school-aged children who meet the DSM-5 criteria for specific learning disorder (SLD) with dyslexia, followed by a structured intervention combining AI-based phonological training and rTMS over six weeks. Participants will undergo baseline assessments, including neuroimaging for a subset, to evaluate their reading abilities before and after the intervention. The goal is to determine if this combined approach can enhance reading skills more effectively than traditional methods alone.

Why it matters

Potential benefit: If successful, this approach could significantly improve reading abilities in children with dyslexia, offering a new avenue for treatment.

How similar studies have gone: Previous studies have shown promising results with neuromodulation techniques like rTMS in treating learning disorders, suggesting potential for success in this novel combination approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Indian school going children aged 6-18 years having specific learning disorder (SLD) with dyslexia diagnosed by DSM-5 criteria
* English as one of the languages in school
* Parents willing for the study

Exclusion Criteria:

* Parents not willing to participate or follow up at desired frequency of study
* Child who has already received or is on remedial intervention within last 12 weeks provided by Child Psychologist/ Clinician/Psychiatrist
* Children who participated in a completed DM dissertation on remedial program in SLD
* Child already on any psychotropic medications
* Neurological or psychiatric disorder other than comorbid disorders of SLD
* Uncontrolled epilepsy as defined by seizure frequency \>1/month for preceding 3 months
* Severe concurrent illness or disease or unstable medical conditions
* Any contraindications for MRI like presence of pacemaker, metallic implant
* Any contraindications for TMS like Implanted electronic device and non-removable metallic objects near coil e.g. pacemaker, cochlear implant; presence of ferromagnetic metal in the head outside the mouth; on medication lowering seizure threshold.

Where it's running

  • All India Institute of Medical Sciences
    Delhi, India
    Recruiting

Study contacts

  • Principal investigator: Sheffali Gulati — All India Institute of Medical Sciences, New Delh
  • Study coordinator: Sheffali Gulati
  • Email: sheffaligulati@gmail.com
  • Phone: 01126594679

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.